Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
Heshmati
H M
HM
Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, USA.
Hofbauer
L C
LC
D018276:Carcinoma, Medullary / Q000175:diagnosis* / Q000628:therapy; D029721:Drosophila Proteins; D005838:Genotype; D018095:Germ-Line Mutation; D006627:Hirschsprung Disease / Q000175:diagnosis; D006801:Humans; D018813:Multiple Endocrine Neoplasia Type 2a / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D018814:Multiple Endocrine Neoplasia Type 2b / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D010641:Phenotype; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000628:therapy
D029721:Drosophila Proteins; D011518:Proto-Oncogene Proteins; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases; C416649:Ret protein, Drosophila